Comparisian of local treatment by triamcinolon orabase with curcumin orabase in oral Graft-versus-host reaction or disease

Comparisian of local treatment by triamcinolon orabase with curcumin orabase in oral GVHD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201508173144N5

Enrollment

Registered

2016-06-09

Start date

2015-09-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graft-versus-host reaction or disease. Graft-versus-host reaction or disease

Interventions

Intervention 1: Intervention group1: triamcinolone paste, QID, for 30 min, for 4 weeks. Intervention 2: Intervention group 2: Curcumin paste, QID, for 30 min for 4 weeks.

Treatment - Drugs

Intervention group1: triamcinolone paste, QID, for 30 min, for 4 weeks

Intervention group 2: Curcumin paste, QID, for 30 min for 4 weeks

Eligibility

Sex/Gender

All

Age

16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being a patient with Oral Graft-versus-host reaction or disease. Exclusion criteria: taking another medication.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ulcer pain. Timepoint: One week after intervention. Method of measurement: Visual Analogue Scale (VAS).;Ulcer size. Timepoint: One week after intervention. Method of measurement: Kolis.	—

Secondary

Measure	Time frame
Ulcer healing. Timepoint: One week after intervention. Method of measurement: Clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahabodin Babaei Fard

Dental Faculty, Tehran University of Medical Sciences

dr.babaeifard@gmail.com+98 21 8835 1152

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026